Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP63955.RAlGXiTcmApAFeA_n_o8eMgkCw6Lsq7B7FpBVG7FRLssw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP63955.RAlGXiTcmApAFeA_n_o8eMgkCw6Lsq7B7FpBVG7FRLssw130_assertion type Assertion NP63955.RAlGXiTcmApAFeA_n_o8eMgkCw6Lsq7B7FpBVG7FRLssw130_head.
- NP63955.RAlGXiTcmApAFeA_n_o8eMgkCw6Lsq7B7FpBVG7FRLssw130_assertion description "[Genetic variants in CDKN2A/B, CDKAL1, TCF7L2, TCF2, MC4R, and PPARG showed a nominal association with type 2 diabetes (P<or=0.05), of whom the three first would stand correction for multiple testing: CDKN2A/B rs10811661, OR: 1.26 (1.12-1.43) P = 1.8*10(-4); CDKAL1 rs10946398, OR: 1.23 (1.09-1.39); P = 7.1*10(-4), and TCF7L2 rs7903146, OR: 1.61 (1.19-2.18) P = 2.3 * 10(-3).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP63955.RAlGXiTcmApAFeA_n_o8eMgkCw6Lsq7B7FpBVG7FRLssw130_provenance.
- NP63955.RAlGXiTcmApAFeA_n_o8eMgkCw6Lsq7B7FpBVG7FRLssw130_assertion evidence source_evidence_literature NP63955.RAlGXiTcmApAFeA_n_o8eMgkCw6Lsq7B7FpBVG7FRLssw130_provenance.
- NP63955.RAlGXiTcmApAFeA_n_o8eMgkCw6Lsq7B7FpBVG7FRLssw130_assertion SIO_000772 20161779 NP63955.RAlGXiTcmApAFeA_n_o8eMgkCw6Lsq7B7FpBVG7FRLssw130_provenance.
- NP63955.RAlGXiTcmApAFeA_n_o8eMgkCw6Lsq7B7FpBVG7FRLssw130_assertion wasDerivedFrom gad-20130706 NP63955.RAlGXiTcmApAFeA_n_o8eMgkCw6Lsq7B7FpBVG7FRLssw130_provenance.
- NP63955.RAlGXiTcmApAFeA_n_o8eMgkCw6Lsq7B7FpBVG7FRLssw130_assertion wasGeneratedBy ECO_0000203 NP63955.RAlGXiTcmApAFeA_n_o8eMgkCw6Lsq7B7FpBVG7FRLssw130_provenance.